Treatment Across the Prostate Cancer Continuum: Current Practice and Future Directions
Target Audience
Learning Objectives
- Have increased knowledge regarding the
- Latest clinical data on therapies, including oral anti-androgens, across the prostate cancer continuum
- Have greater competence related to
- Identifying candidates for select therapies in prostate cancer reflective of disease-specific factors
- Mitigating adverse events (AEs) associated with oral anti-androgen therapies
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Participation
FACULTY
Professor of Oncology
Institut Gustave Roussy
University of Paris-Saclay
Villejuif, France
Adjunct Professor
Department of Urologic Sciences
University of British Columbia
Medical Director
Prostate Cancer Supportive Care Program
Vancouver Prostate Centre
Vancouver, British Columbia, Canada
Assistant Professor of Medicine
UChicago Medicine
Chicago, Illinois, United States
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Other Healthcare Professions Credit
Click here to view the activity or if you are logged in click on the "Complete Activity" button!